568 related articles for article (PubMed ID: 26203193)
1. Finerenone Impedes Aldosterone-dependent Nuclear Import of the Mineralocorticoid Receptor and Prevents Genomic Recruitment of Steroid Receptor Coactivator-1.
Amazit L; Le Billan F; Kolkhof P; Lamribet K; Viengchareun S; Fay MR; Khan JA; Hillisch A; Lombès M; Rafestin-Oblin ME; Fagart J
J Biol Chem; 2015 Sep; 290(36):21876-89. PubMed ID: 26203193
[TBL] [Abstract][Full Text] [Related]
2. Antagonistic effects of finerenone and spironolactone on the aldosterone-regulated transcriptome of human kidney cells.
Le Billan F; Perrot J; Carceller E; Travers S; Viengchareun S; Kolkhof P; Lombès M; Fagart J
FASEB J; 2021 Feb; 35(2):e21314. PubMed ID: 33417258
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological profile of CS-3150, a novel, highly potent and selective non-steroidal mineralocorticoid receptor antagonist.
Arai K; Homma T; Morikawa Y; Ubukata N; Tsuruoka H; Aoki K; Ishikawa H; Mizuno M; Sada T
Eur J Pharmacol; 2015 Aug; 761():226-34. PubMed ID: 26073023
[TBL] [Abstract][Full Text] [Related]
4. The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
Gravez B; Tarjus A; Jimenez-Canino R; El Moghrabi S; Messaoudi S; Alvarez de la Rosa D; Jaisser F
PLoS One; 2013; 8(9):e73737. PubMed ID: 24040049
[TBL] [Abstract][Full Text] [Related]
5. Steroidal and Novel Non-steroidal Mineralocorticoid Receptor Antagonists in Heart Failure and Cardiorenal Diseases: Comparison at Bench and Bedside.
Kolkhof P; Jaisser F; Kim SY; Filippatos G; Nowack C; Pitt B
Handb Exp Pharmacol; 2017; 243():271-305. PubMed ID: 27830348
[TBL] [Abstract][Full Text] [Related]
6. Finerenone, a novel selective nonsteroidal mineralocorticoid receptor antagonist protects from rat cardiorenal injury.
Kolkhof P; Delbeck M; Kretschmer A; Steinke W; Hartmann E; Bärfacker L; Eitner F; Albrecht-Küpper B; Schäfer S
J Cardiovasc Pharmacol; 2014 Jul; 64(1):69-78. PubMed ID: 24621652
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.
Jaffe IZ; Mendelsohn ME
Circ Res; 2005 Apr; 96(6):643-50. PubMed ID: 15718497
[TBL] [Abstract][Full Text] [Related]
8. Histone deacetylase inhibition, but not a mineralocorticoid receptor antagonist spironolactone, attenuates atypical transcription by an activating mutant MR (MRS 810L ).
Kang SH; Lee HA; Lee E; Kim M; Kim I
Clin Exp Pharmacol Physiol; 2016 Oct; 43(10):995-1003. PubMed ID: 27362706
[TBL] [Abstract][Full Text] [Related]
9. The ligand-dependent interaction of mineralocorticoid receptor with coactivator and corepressor peptides suggests multiple activation mechanisms.
Hultman ML; Krasnoperova NV; Li S; Du S; Xia C; Dietz JD; Lala DS; Welsch DJ; Hu X
Mol Endocrinol; 2005 Jun; 19(6):1460-73. PubMed ID: 15761029
[TBL] [Abstract][Full Text] [Related]
10. Selective Mineralocorticoid Receptor Cofactor Modulation as Molecular Basis for Finerenone's Antifibrotic Activity.
Grune J; Beyhoff N; Smeir E; Chudek R; Blumrich A; Ban Z; Brix S; Betz IR; Schupp M; Foryst-Ludwig A; Klopfleisch R; Stawowy P; Houtman R; Kolkhof P; Kintscher U
Hypertension; 2018 Apr; 71(4):599-608. PubMed ID: 29437893
[TBL] [Abstract][Full Text] [Related]
11. The non-steroidal mineralocorticoid receptor antagonist finerenone prevents cardiac fibrotic remodeling.
Lavall D; Jacobs N; Mahfoud F; Kolkhof P; Böhm M; Laufs U
Biochem Pharmacol; 2019 Oct; 168():173-183. PubMed ID: 31283930
[TBL] [Abstract][Full Text] [Related]
12. Finerenone : third-generation mineralocorticoid receptor antagonist for the treatment of heart failure and diabetic kidney disease.
Liu LC; Schutte E; Gansevoort RT; van der Meer P; Voors AA
Expert Opin Investig Drugs; 2015; 24(8):1123-35. PubMed ID: 26095025
[TBL] [Abstract][Full Text] [Related]
13. Nonsteroidal mineralocorticoid receptor antagonism for cardiovascular and renal disorders - New perspectives for combination therapy.
Kolkhof P; Joseph A; Kintscher U
Pharmacol Res; 2021 Oct; 172():105859. PubMed ID: 34461222
[TBL] [Abstract][Full Text] [Related]
14. Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion.
Caprio M; Newfell BG; la Sala A; Baur W; Fabbri A; Rosano G; Mendelsohn ME; Jaffe IZ
Circ Res; 2008 Jun; 102(11):1359-67. PubMed ID: 18467630
[TBL] [Abstract][Full Text] [Related]
15. Class-specific responses of brown adipose tissue to steroidal and nonsteroidal mineralocorticoid receptor antagonists.
Marzolla V; Feraco A; Limana F; Kolkhof P; Armani A; Caprio M
J Endocrinol Invest; 2022 Jan; 45(1):215-220. PubMed ID: 34272678
[TBL] [Abstract][Full Text] [Related]
16. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
[TBL] [Abstract][Full Text] [Related]
17. NF-YC functions as a corepressor of agonist-bound mineralocorticoid receptor.
Murai-Takeda A; Shibata H; Kurihara I; Kobayashi S; Yokota K; Suda N; Mitsuishi Y; Jo R; Kitagawa H; Kato S; Saruta T; Itoh H
J Biol Chem; 2010 Mar; 285(11):8084-93. PubMed ID: 20054001
[TBL] [Abstract][Full Text] [Related]
18. Differences in the determinants of eplerenone, spironolactone and aldosterone binding to the mineralocorticoid receptor.
Rogerson FM; Yao Y; Smith BJ; Fuller PJ
Clin Exp Pharmacol Physiol; 2004 Oct; 31(10):704-9. PubMed ID: 15554912
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of the potent sodium-retaining steroid 11, 19-oxidoprogesterone.
Galigniana MD; Vicent GP; Piwien-Pilipuk G; Burton G; Lantos CP
Mol Pharmacol; 2000 Jul; 58(1):58-70. PubMed ID: 10860927
[TBL] [Abstract][Full Text] [Related]
20. Contrasting effects of eplerenone and spironolactone on adrenal cell steroidogenesis.
Ye P; Yamashita T; Pollock DM; Sasano H; Rainey WE
Horm Metab Res; 2009 Jan; 41(1):35-9. PubMed ID: 18819053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
